Article
The Role Of Early TP53 Mutations On The Evolution Of Therapy-Related AML
2013-11-15
Abstract excerpt
Abstract Therapy-related acute myeloid leukemia (t-AML) and therapy-related myelodysplastic syndrome (t-MDS) are well-recognized complications of cytotoxic chemotherapy and/or radiotherapy. Compared to de novo AML, there is a higher incidence of TP53 mutations, abnormalities of chromosomes 5 or 7, and complex cytogenetics in t-AML. The response to chemotherapy is also reduced compared to de novo AML, and long-term...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 30cb1a24-5c2a-5fc1-b280-65d746a98af7
- DOI
- 10.1182/blood.v122.21.5.5
